Breaking News Instant updates and real-time market news.

TWX

Time Warner

$91.35

0.66 (0.73%)

, DIS

Disney

$98.24

-1.13 (-1.14%)

15:59
11/20/16
11/20
15:59
11/20/16
15:59

Box Office Battle: Harry Potter spinoff 'Fantastic Beasts' debuts at $75M

Time Warner's (TWX) "Fantastic Beasts And Where To Find Them" earned $75M in its U.S. debut over the November 20 weekend, slightly underperforming against forecasts of $80M-$90M. The film, an Eddie Redmayne-led offshoot of the "Harry Potter" series, received an A in audience polls from CinemaScore, holds a 76% approval rating on reviews aggregator RottenTomatoes, and was produced with a reported budget of $180M. In foreign markets, "Fantastic Beasts" took $143.3M. BOX OFFICE RUNNERS-UP: Disney's (DIS) "Doctor Strange" added $17.7M in its third domestic weekend, reaching cumulative U.S. and international totals of $181.5M and $390M, respectively. Taking third place, Fox's (FOX) animated film "Trolls" grossed $17.5M. Rounding out the top five, Viacom's (VIA) sci-fi drama "Arrival" earned $11.8M in its second weekend, while Comcast's (CMCSA) seasonal comedy "Almost Christmas" opened at $7M. Other publicly traded companies in filmmaking include Sony (SNE) and Lionsgate (LGF).

TWX

Time Warner

$91.35

0.66 (0.73%)

DIS

Disney

$98.24

-1.13 (-1.14%)

FOX

21st Century Fox

$27.69

-0.12 (-0.43%)

FOXA

21st Century Fox

$27.82

-0.1 (-0.36%)

VIA

Viacom

$42.05

-0.7 (-1.64%)

VIAB

Viacom

$37.77

-0.84 (-2.18%)

CMCSA

Comcast

$68.34

-0.15 (-0.22%)

CMCSK

Comcast

SNE

Sony

$29.18

-0.52 (-1.75%)

LGF

Lionsgate

$23.23

-0.03 (-0.13%)

  • 28

    Nov

  • 05

    Dec

TWX Time Warner
$91.35

0.66 (0.73%)

11/17/16
11/17/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Microsoft (MSFT) upgraded to Buy from Neutral at Goldman with analyst Heather Bellini saying Azure is the number two market share vendor in the cloud space, and has grown 100% or more year-over-year eight of the last 10 quarters. 2. Time Warner (TWX) upgraded to Buy from Sell at MoffettNathanson. 3. First Solar (FSLR) upgraded at JMP Securities with analyst Joseph Osha citing valuation. 4. KBR (KBR) upgraded to Buy from Neutral at BofA Merrill Lynch with analyst Anna Kaminskaya saying she expects structurally higher defense spending to drive a re-rating in KBR and sees less risk of cost overruns in the E&C business given lower reliance on fixed priced contracts and diversification into smaller sized service projects. 5. Liberty Interactive (QVCA) upgraded to Buy from Neutral at BofA Merrill Lynch with analyst Heather Balsky saying she has increased confidence in a return to positive US sales growth and expects multiple expansion as sales improve. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
MOFT
11/17/16
UPGRADE
MOFT
Buy
Time Warner upgraded to Buy from Sell at MoffettNathanson
11/08/16
OPCO
11/08/16
DOWNGRADE
OPCO
Perform
AT&T downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Timothy Horan downgraded AT&T (T) to Perform saying CenturyLink's (CTL) dividend is "relatively more attractive." The analyst this morning upgraded CenturyLink to Outperform. Horan also believes AT&T's acquisition of Time Warner (TWX) will face higher regulatory hurtles than CenturyLink's deal for Level 3 (LVLT). He expects the Time Warner deal to take 15 months to complete versus nine months for the Level 3 acquisition.
11/07/16
11/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Time Warner (TWX) upgraded to Outperform from Neutral at Credit Suisse with analyst Omar Sheikh citing attractive valuation. 2. Waste Management (WM) upgraded to Overweight from Equal Weight at Barclays with analyst Jon Windham saying the recent pullback in shares provides a buying opportunity given the company's "strong" underlying fundamentals. 3. Parker-Hannifin (PH) upgraded to Buy from Hold at Evercore ISI and to Overweight from Equal Weight at Morgan Stanley. 4. Biogen (BIIB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Joshua Schimmer saying the company still has time to "get its act together to maximize the value of its SMA franchise, and stop being M&A disciplined/pipeline-undisciplined." 5. Cummins (CMI) upgraded to Buy from Hold at Evercore ISI with analyst David Raso citing lowered expectations, valuation, and accelerating inflation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DIS Disney
$98.24

-1.13 (-1.14%)

11/16/16
DBAB
11/16/16
UPGRADE
Target $112
DBAB
Buy
Disney upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Bryan Kraft upgraded The Walt Disney Company to Buy citing increased confidence in the company's outlook for 2017. ESPN subscriber declines have improved and should improve further with the proliferation of streaming pay TV bundles in 2017, Kraft tells investors in a research note. He believes declines in the Consumer Products business will trough in the December quarter and feels the tough film comps for 2017 are well understood. Kraft has a $112 price target for Disney shares. The stock closed yesterday down 24c to $97.70.
11/15/16
ROTH
11/15/16
NO CHANGE
Target $38
ROTH
Buy
Roth Capital likes IMAX partnership with Disney-ABC, Marvel Television
Following IMAX's (IMAX) announcement of its partnership with Disney's (DIS) ABC and Marvel Television to have the new TV series "The InHumans" first two episodes debut exclusively on the company's network, Roth Capital analyst Darren Aftahi says he likes this transaction. The analyst believes it diversifies IMAX away from its reliance on tent pole content, raises brand awareness, and gives it a financial participation in the ongoing success of TV series. He reiterates a Buy rating and $38 price target on IMAX's shares.
11/16/16
11/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Buy from Hold at Deutsche Bank with analyst Bryan Kraft citing increased confidence in the company's outlook for 2017. 2. Fitbit upgraded to Sector Weight from Underweight at Pacific Crest with analyst Brad Erickson citing valuation. 3. Copa Holdings (CPA) upgraded to Buy from Neutral at Goldman with analyst Marcio Prado saying Copa is well positioned for an expected recovery cycle given more rationalized sector capacity and improved yields, and structural advantages. 4. Fossil upgraded to Overweight from Underweight at Pacific Crest with analyst Edward Yruma saying he expects the company to benefit from continuing "strong momentum in wearables." 5. Juniper (JNPR) upgraded to Conviction Buy from Buy at Goldman with analyst Simona Jankowski saying she expects new switching products to drive top and bottom-line growth in 2017 and views valuation as attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
SBSH
11/17/16
NO CHANGE
Target $117
SBSH
Buy
Citi views Disney's moves as blunting the bear thesis
Citi analyst Jason Bazinet believes Disney in 2016 made three "bold' announcements that are yet to be fully developed by the Street. First, the company in Q2 acquired a 33% stake in BAMTech. Second, it suggested it would use Hulu to launch a sports-centric linear TV service in early 2017. And third, management suggested they would launch a niche sports service for out-of-market games. These strategic pivots blunt the bear case which is centered on cord cutters, Bazinet tells investors in a research note. Disney bears are focused on the 2% of U.S. households that terminate their pay TV subscription each year, the analyst writes. He estimates that absent steps by Disney, cord cutting creates a financial headwind of about $300M a year. With Disney's three announcements, however, the $300M headwind could shrink each year and actually turn into a $100M EBIT tailwind by 2020, the analyst contends. Bazinet keeps a Buy rating on Disney with a $117 price target.
FOX 21st Century Fox
$27.69

-0.12 (-0.43%)

09/06/16
RHCO
09/06/16
NO CHANGE
Target $18
RHCO
Neutral
SunTrust sees 'limited' list of Twitter suitors, says activist action unlikely
SunTrust analyst Robert Peck reiterated his belief that Twitter (TWTR) is unlikely to sell itself in 2016 in a new note to investors, but noted that investors have asked him who would be interested if Twitter were open to a sale. While giving his opinion on potential acquirers - which he sees possibly including Google (GOOG), Facebook (FB), Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), AT&T (T), Verizon (VZ), Disney (DIS), Fox (FOXA), and Alibaba (BABA) - Peck said the company's high price and "unique" asset limit the potential buyers and gave his view that a PE buyer is highly unlikely given the company's lack of free cash flow. Additionally, Peck thinks activist action at Twitter seems "extremely unlikely" despite "unsubstantiated investor conjecture" and media reports. The analyst keeps Neutral rating and $18 price target on Twitter shares.
09/15/16
BERN
09/15/16
DOWNGRADE
BERN
Market Perform
21st Century Fox downgraded to Market Perform from Outperform at Bernstein
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/16
UBSW
09/26/16
NO CHANGE
Target $92
UBSW
Neutral
Consumer satisfaction with competitors has caught up to Netflix, says UBS
UBS analyst Doug Mitchelson said that the firm's Evidence Lab survey indicated that U.S. consumer satisfaction with Amazon Prime Video (AMZN) and Hulu - the joint venture owned by Time Warner (TWX), Comcast (CMCSA), 21st Century Fox (FOXA), and Disney (DIS) - has now caught up to Netflix (NFLX), advising that investors should "continue to monitor competitive threats closely" as Netflix leads the category but demand for consumer media time, attention and wallet has intensified. The analyst, who added that Netflix's "pricing power remains unclear" based on the firm's survey work, keeps a Neutral rating and $92 price target on Netflix shares.
FOXA 21st Century Fox
$27.82

-0.1 (-0.36%)

10/14/16
RBCM
10/14/16
NO CHANGE
RBCM
21st Century Fox setup into results positive, says RBC Capital
RBC Capital analyst Steven Cahall thinks that 21st Century Fox's stock will react positively to its Q1 results despite the weak performance of its films and "mild weakness" in broadcast ratings. If no other problems emerge, the stock can rise, the analyst believes. He thinks that the stock's valuation is attractive
10/27/16
PACS
10/27/16
NO CHANGE
PACS
21st Century Fox should be owned into Q1 results, says Pacific Crest
Pacific Crest analyst Andy Hargreaves says that 21st Century Fox can meet consensus Q1 estimates, and he believes that that the stock will probably rise if the company does so. The analyst says that the stock is his favorite among TV networks, and he recommends owning the shares ahead of the earnings.
VIA Viacom
$42.05

-0.7 (-1.64%)

10/20/16
BMUR
10/20/16
NO CHANGE
Target $65
BMUR
Buy
CBS extraordinarily well positioned, says Brean Capital
Brean Capital analyst Alan Gould said CBS (CBS) is extraordinarily well positioned with two core networks, predictable retrans/reverse comp driving growth and only modest programming expense increases as its key sports contracts are locked in. Gould believes CBS would only combine with Viacom (VIA) if it was financially favorable to CBS shareholders and management. Gould reiterated his Buy rating and $65 price target on CBS shares.
10/17/16
WEDB
10/17/16
UPGRADE
Target $46
WEDB
Outperform
Viacom upgraded to Outperform from Neutral at Wedbush
Wedbush analyst James Dix upgraded Viacom (VIAB) to Outperform citing increasing likelihood of a merger with CBS (CBS). The analyst assigns a 75% probability on a merger, which he assumes would be an all-stock transaction. He raised his price target for Viacom shares to $46 from $40.
11/14/16
BMUR
11/14/16
DOWNGRADE
BMUR
Hold
Viacom downgraded to Hold from Buy at Brean Capital
Brean Capital analyst Alan Gould downgraded Viacom (VIAB) to Hold with a fair value estimate for shares of $40. The analyst questions the "true synergies" between Viacom and CBS (CBS) and believes combining the two companies does not maximize value. Viacom closed Friday up 41c to $38.42.
11/15/16
FBRC
11/15/16
DOWNGRADE
Target $44
FBRC
Market Perform
Viacom downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Barton Crockett downgraded Viacom (VIAB) to Market Perform saying he sees a better risk/reward in CBS (CBS) until the "merger noise is cleared." The analyst lowered his price target for Viacom shares to $44 from $56.
VIAB Viacom
$37.77

-0.84 (-2.18%)

11/14/16
11/14/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AB InBev (BUD) downgraded to Hold from Buy at HSBC with analyst Anthony Bucalo citing business pressures in the U.S. and Brazil as well as uncertainty post the U.S. election. 2. Abercrombie (ANF) and American Eagle (AEO) downgraded to Peer Perform from Outperform at Wolfe Research. 3. Capital One (COF) downgraded to Hold from Buy at Stifel with analyst Christopher Brendler saying he believes that the stock has become less attractive following its recent rally, and he thinks that changes made by the Trump Administration won't be felt by the company "for years." 4. SeaWorld (SEAS) downgraded to Neutral from Buy at Citi with analyst Jason Bazinet saying the risk/reward is no longer compelling following the recent bounce in the shares. 5. Viacom (VIAB) downgraded to Hold from Buy at Brean Capital with analyst Alan Gould questioning the "true synergies" between Viacom and CBS (CBS) and believes combining the two companies does not maximize value. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CMCSA Comcast
$68.34

-0.15 (-0.22%)

10/27/16
OPCO
10/27/16
NO CHANGE
Target $74
OPCO
Outperform
Comcast solid quarter overshadowed by OTT, wireless threats, says Oppenheimer
Oppenheimer analyst Timothy Horan says Comcast (CMCSA; CMCSK) reported a "solid" Q3, but notes that shares were likely impacted by comments surrounding AT&T's (T) $35 Over The Top service, which will be a slimmed-down service designed to expand the overall market initially. While the analyst points out that the "legitimate concern" is a wireless acquisition of T-Mobile (TMUS), he thinks this is a 2018 event and that Comcast can integrate cellular/WIFI to create a unique service. Horan reiterates an Outperform rating and $74 price target on Comcast's shares.
10/24/16
JEFF
10/24/16
NO CHANGE
Target $48
JEFF
Buy
Jefferies says approval of Time Warner deal 'far from certain'
Jefferies analyst Mike McCormack believes regulatory approval of AT&T's (T) Time Warner acquisition is "far from certain." The analyst expects a "lengthy and arduous regulatory process" and believes the Comcast-NBCU deal serves as "both a precedent and a concern." The deal looks "modestly accretive" with "relatively small synergies," McCormack tells investors in a research note. He keeps a Buy rating on AT&T with a $48 price target.
10/24/16
MACQ
10/24/16
UPGRADE
Target $77
MACQ
Outperform
Comcast upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Amy Yong upgraded Comcast (CMCSA) to Outperform and raised its price target to $77 from $69 saying the AT&T (T)/Time Warner (TWX) and Starz (STRZA)-Lionsgate (LGF) deals highlight the merits of distribution content. Yong said Comcast is becoming a one-stop shop for all things consumer with wireless optionality, digital initiatives, and Xfinity's brand paired with strategic acquisitions like DreamWorks and BuzzFeed. The analyst said Comcast's balance sheet optionality leaves room for further vertical deals and said its DreamWorks' TV business, library of content, and direct piper into China are heavenly undervalued.
10/31/16
JPMS
10/31/16
NO CHANGE
JPMS
Overweight
TiVo deal renewal shows IP portfolio strong, says JPMorgan
JPMorgan analyst Sterling Auty believes the worldwide multi-year renewal license with Panasonic (PCRFY) is another sign that TiVo's intellectual property portfolio remains strong. TiVo is positioned to land the last remaining pay TV operator out of contract in the U.S., Comcast (CMCSA), Auty tells investors in a research note. He keeps an Overweighrt rating on TiVo.
CMCSK Comcast

08/22/16
PIPR
08/22/16
NO CHANGE
Target $27
PIPR
Overweight
Piper Jaffray confident in Comcast signing with Rovi
Piper Jaffray analyst Michael Olson notes that Rovi (ROVI) announced a 10-year renewal with DISH (DISH) and while the terms were not disclosed, economics should be similar to recent deals, likely in the range of 21c-22c per subscriber per month. With DISH in the fold, nine of the ten major U.S. TV service providers now license Rovi guide patents, the analyst said, with Comcast (CMCSA; CMCSK) remaining the lone holdout. Olson believes discussions with Comcast are at the economic level, and is confident in Comcast signing, potentially in the first half of 2017. He reiterates an Overweight rating and $27 price target on Rovi's shares.
08/22/16
JPMS
08/22/16
NO CHANGE
JPMS
Overweight
DISH renewal a major positive for Rovi, says JPMorgan
JPMorgan analyst Sterling Auty said he views Rovi's (ROVI) newly-announced 10-year contract renewal with DISH Networks (DISH) as a "major positive" that should help Rovi's position to complete its renewal with Comcast (CMCSA), which is the only top 10 pay-TV provider not currently under contract with the company. The announcement language suggests pricing "somewhere just above" that given to AT&T (T) and the duration of the deal validates the longevity of the patent portfolio, said Auty, who keeps an Overweight rating on Rovi shares.
SNE Sony
$29.18

-0.52 (-1.75%)

09/09/16
PIPR
09/09/16
NO CHANGE
PIPR
August NPD video game software sales rose 1%, says Piper Jaffray
Piper Jaffray analyst Michael Olson says August NPD video game software sales were up 1% year-over-year, driven by Sony (SNE) publishing No Man's Sky and Electronic Arts' (EA) Madden NFL 17. The data are most positive for Activision Blizzard (ATVI), which continued to benefit from sell-through of incremental title Overwatch, Olson tells investors in a research note. He believes the monthly numbers are largely irrelevant for Take-Two (TTWO), since NBA 2K17 is due out in September, and GameStop (GME), since the company announced October quarter guidance at the end of August.
08/24/16
STFL
08/24/16
NO CHANGE
STFL
Ambarella Q2 revenue guidance could beat expectations, says Stifel
Stifel analyst Kevin Cassidy says he is "cautiously optimistic" that Ambarella's (AMBA) Q2 revenue guidance will come in above expectations. The company was worried about whether Sony (SNE) would be able to meet demand for its sensors used in high end surveillance cameras, but recent checks show that it was able to do so, the analyst stated. Additionally, Ambarella's Q3 guidance should project year-over-year growth, given GoPro's (GPRO) initial Hero 5 builds, according to Cassidy. He keeps an $86 price target and Buy rating on Ambarella.
08/18/16
PIPR
08/18/16
NO CHANGE
Target $41
PIPR
Overweight
Piper Jaffray bullish on GameStop ahead of quarterly results
With GameStop (GME) scheduled to report results next week, Piper Jaffray analyst Michael Olson sees potential for slight July quarter upside driven by May launches of Sony's (SNE) Uncharted 4 and Activision's (ATVI) Overwatch. Further, the analyst expects largely unchanged fiscal year guide, and anticipates improving software growth in the second half of the year, driven by easier comps and a next-generation console footprint that he believes is over 60M units. Olson reiterates an Overweight rating and $41 price target on GameStop's shares.
07/06/16
07/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. TASER (TASR) upgraded to Buy from Neutral at CL King with analyst George Godfrey citing strong organic growth, a leading position in body cameras, low international market exposure, accelerating earnings growth and margin expansion, and weapons segment opportunity growth. 2. Sony (SNE) upgraded to Buy from Hold at Deutsche Bank with analyst Hiroshi Taguchi saying the company's shipment growth will likely exceed expectations. 3. U.S. Steel (X) upgraded to Hold from Sell at Deutsche Bank with analyst Jorge Beristain citing his firm's improved steel price outlook as well as the company's' balance sheet refinancing. 4. SunPower (SPWR) upgraded to Buy from Neutral at UBS with Julien Dumoulin-Smith citing valuation, a strong technology track record and product development, early indications that utility scale margins are proving more intact versus expectations, and a solid balance sheet. 5. Royal Gold (RGLD) upgraded to Outperform from Market Perform at Raymond James and to Buy from Neutral at Dundee. Raymond James analyst Phil Russo upgraded Royal Gold to Outperform and increased his price target to $85 from $72 following amended terms at Mt Milligan with new operator Centerra Gold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LGF Lionsgate
$23.23

-0.03 (-0.13%)

11/04/16
PACS
11/04/16
NO CHANGE
PACS
Lionsgate results positive, says Pacific Crest
Pacific Crest analyst Evan Wingren says that Lionsgate's in-line results and guidance are positive, given its multiple negative revisions over the past year. The analyst says that the company "is relatively well-positioned" versus its media peers, while the shares are "relatively cheap." He recommends owning the stock.
11/04/16
RBCM
11/04/16
UPGRADE
RBCM
Outperform
Lionsgate upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Steven Cahall upgraded Lionsgate (LGF) as he believes that the market has not adequately appreciated the cash synergies produced by the company's merger with Starz (STRZA). He says that Lionsgate is "significantly undervalued." Target to $31 from $24.
10/31/16
MSCO
10/31/16
INITIATION
Target $25
MSCO
Overweight
Lionsgate initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Ryan Fiftal initiated Lionsgate (LGF) with an Overweight and a $25 price target. The analyst said shares have been hit due to film underperformance and the recent Starz (STRZA), resulting in favorable risk/reward. The analyst sees opex synergies, healthy TV studio growth, and recent Starz top line strength from new, higher margin digital distribution.
10/28/16
STFL
10/28/16
UPGRADE
STFL
Buy
Starz upgraded on subscriber data, cost outlook at Stifel
As noted earlier, Stifel analyst Benjamin Mogil upgraded Starz (STRZA) to Buy from Hold. Mogil notes that the company reported higher than expected revenue from subscribers in Q3 and indicated that its costs would be lower than expected for the full year. Target to $36 from $33. Mogil also upgraded Lionsgate (LGF), with whom Starz has agreed to merge, to Buy from Hold.

TODAY'S FREE FLY STORIES

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.